Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : NEW Market Gems - Swing and Day Trades -- Ignore unavailable to you. Want to Upgrade?

To: Rick Buskey who wrote (631)	6/5/2001 3:25:10 PM
From: Jenna	Read Replies (1) \| Respond to of 1227

RDEN -Elizabeth Arden Inc., $25.03 Rated 1H Kenneth F. Smith, CFA A sweet smelling investment opportunity: Elizabeth Arden, Inc., one of the U.S.' premier prestige fragrance and beauty products companies. Initiating coverage with BUY rating and $35 initial price target, with upside closer to $60, in our view, given comp valuations and EPS growth potential. FY༾ focus to be on integrating the Elizabeth Arden business acquired from Unilever in January 2001 which more than doubled the size of the company. FY༿ estimate of $2.40 (up 60% from FY༾) assumes no operational synergies resulting from the acquisition or margin improvement = significant potential upside. We estimate RDEN has a 19% share of the U.S. fragrance business and is uniquely positioned with the industry's largest brand portfolio and multi-channel distribution. Valuation very compelling: current EV/2002E EBITDA multiple of 4.8x more than 50% below comparable companies; 8x-10x multiple more realistic, in our view, given company's size, profitability, and market position